| Predicate |
Object |
| contentType |
Comment|Journal Article |
| issn |
0094-3509 |
| issueIdentifier |
9 |
| pageRange |
789- |
| publicationName |
The Journal of family practice |
| startingPage |
789 |
| bibliographicCitation |
Lindbloom EJ, Eaton LJ. Cost effectiveness of aspirin vs clopidogrel for secondary prevention of coronary heart disease. J Fam Pract. 2002 Sep;51(9):789. PMID: 12366903. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_34b552d7a24a808f168b901e07bf1d78
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea8923a1b10ab50229c0dd91bf3d7532 |
| date |
200209 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/12366903 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0094-3509
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4734 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Cost effectiveness of aspirin vs clopidogrel for secondary prevention of coronary heart disease |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7347
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606 |